Stage
No active trials
Next date
None yet
Trials
6 active
9 in total · 7 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “A total of 700 mL of drug product will be administered orally as a split dose before surgery.”In the company’s words, NCT05470387 on ClinicalTrials.gov
- Tested for
- Ileus (2 trials), Gastro-Intestinal Disorder, Post-Operative Adhesions
- Main trialPhase 3
- “The purpose of this study is to evaluate the safety and efficacy of LB1148 in subjects undergoing planned bowel resection.”In the company’s words, NCT05470387 on ClinicalTrials.gov
- Other names
- Active
Other drugs for Gastro-Intestinal Disorder
- DostarlimabGSK · Phase 3
- CadonilimabAkeso · Phase 3
- DurvalumabAstraZeneca · Phase 3
- TremelimumabAstraZeneca · Phase 3
- Anlotinib HydrochlorideChia Tai Tianqing Pharmaceutical Group Co., Ltd. · Phase 3
- BudigalimabAbbVie · Phase 2/3
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials9
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Terminated | 6 Mar 2023 | A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection | |
| Phase 2Completed | 6 Sep 2023 | A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection | |
| Phase 2Authorised | not given | Dose Study of Tranexamic Acid in Total Hip Replacement to Reduce Postoperative Hemoglobin Loss. A Phase 2 Randomized Double-blind Monocentric Study. The PRADO study | |
| Phase 4Authorised | not given | A parallel-group treatment, Phase 4, prospective multicenter double-blind randomized 2-arm placebo-controlled study to investigate the effect of single dose topical administration of tranexamic acid vs placebo onto surgical wound surfaces on postoperative re-bleeding, wound complications, seroma and thromboembolic events in male and female patients above 18 years of age undergoing plastic surgery. | |
| Phase 3Authorised | not given | TRAnexamic Acid for Preventing blood loss following a cesarean delivery in women with placenta pREVIA or low-lying placenta : a multicenter randomised, double blind placebo controlled trial. TRAAPrevia | |
| Phase 4Ended | not given | “Randomized, double-blind clinical trial to assess the efficacy of tranexamic acid in reducing blood loss in patients with hip fracture”. | |
| Phase 3Authorised | not given | MULTICENTER, DOUBLE BLIND CLINICAL TRIAL TO EVALUATE THE ANTIHEMORRAGIC EFFECT OF THE TOPICAL TRANEXAMIC ACID DURING PACEMAKER IN ANTICOAGULATED PATIENTS | |
| Phase 3Authorised | not given | Tranexamic Acid in Hind and Midfoot Arthrodesis Surgery: A Multicentre, Randomized, Placebo-Controlled Trial (TRASH Trial) | |
| Phase 4Authorised | not given | Oral versus Intravenous Tranexamic Acid for Blood Loss Prevention in Off-Pump Coronary Artery Bypass Surgery: A Randomised Non-Inferiority Trial (TRANSCAB Study) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026